|
SPATA2L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.601000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.196800E-01 |
| Normal-vs-Stage2 |
1.423840E-02 |
| Normal-vs-Stage3 |
9.105200E-01 |
| Normal-vs-Stage4 |
5.004600E-03 |
| Stage1-vs-Stage2 |
2.029800E-04 |
| Stage1-vs-Stage3 |
6.396400E-01 |
| Stage1-vs-Stage4 |
2.207700E-04 |
| Stage2-vs-Stage3 |
4.596200E-02 |
| Stage2-vs-Stage4 |
2.640800E-01 |
| Stage3-vs-Stage4 |
8.244700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.572000E-01 |
| Normal-vs-AfricanAmerican |
6.495600E-01 |
| Normal-vs-Asian |
1.430230E-01 |
| Caucasian-vs-AfricanAmerican |
4.135400E-01 |
| Caucasian-vs-Asian |
2.008600E-01 |
| AfricanAmerican-vs-Asian |
3.586800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.126600E-01 |
| Normal-vs-Female |
2.143000E-01 |
| Male-vs-Female |
2.300000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.568000E-01 |
| Normal-vs-Extreme_Weight |
6.514200E-01 |
| Normal-vs-Obese |
7.150000E-01 |
| Normal-vs-Extreme_Obese |
5.652800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.212830E-01 |
| Normal_Weight-vs-Obese |
1.836600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.906800E-01 |
| Extreme_Weight-vs-Obese |
8.986000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.230800E-01 |
| Obese-vs-Extreme_Obese |
7.820000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.322200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.108600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.423600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.995580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.564800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.579800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.822980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.340600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.443200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.154800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.907800E-01 |
| Normal-VS-Type2 PRCC |
1.556200E-01 |
| Normal-VS-KIRP CIMP |
4.808000E-01 |
| Normal-VS-Unclassified PRCC |
3.219000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.059950E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.032400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.310220E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.899000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.547600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.059800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.846600E-01 |
| Normal-vs-N1 |
3.203000E-01 |
| Normal-vs-N2 |
7.724300E-02 |
| N0-vs-N1 |
7.268800E-01 |
| N0-vs-N2 |
2.953600E-01 |
| N1-vs-N2 |
3.442400E-01 |
|
|
